Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

The 5-HT1B serotonin receptor regulates methylphenidate-induced gene expression in the striatum: Differential effects on immediate-early genes.

Alter D, Beverley JA, Patel R, Bolaños-Guzmán CA, Steiner H.

J Psychopharmacol. 2017 Aug;31(8):1078-1087. doi: 10.1177/0269881117715598. Epub 2017 Jul 18.

PMID:
28720013
2.
3.

Trends in psychotropic polypharmacy among youths enrolled in Ohio Medicaid, 2002-2008.

Fontanella CA, Warner LA, Phillips GS, Bridge JA, Campo JV.

Psychiatr Serv. 2014 Nov 1;65(11):1332-40. doi: 10.1176/appi.ps.201300410. Epub 2014 Oct 31.

4.

Life-long consequences of juvenile exposure to psychotropic drugs on brain and behavior.

Steiner H, Warren BL, Van Waes V, Bolaños-Guzmán CA.

Prog Brain Res. 2014;211:13-30. doi: 10.1016/B978-0-444-63425-2.00002-7. Review.

5.

Effects of psychotropic drugs on second messenger signaling and preference for nicotine in juvenile male mice.

Alcantara LF, Warren BL, Parise EM, Iñiguez SD, Bolaños-Guzmán CA.

Psychopharmacology (Berl). 2014 Apr;231(8):1479-92. doi: 10.1007/s00213-014-3434-4. Epub 2014 Jan 23.

6.

Selective serotonin re-uptake inhibitors potentiate gene blunting induced by repeated methylphenidate treatment: Zif268 versus Homer1a.

Van Waes V, Vandrevala M, Beverley J, Steiner H.

Addict Biol. 2014 Nov;19(6):986-95. doi: 10.1111/adb.12067. Epub 2013 Jun 13.

7.

Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulants.

Steiner H, Van Waes V.

Prog Neurobiol. 2013 Jan;100:60-80. doi: 10.1016/j.pneurobio.2012.10.001. Epub 2012 Oct 17. Review.

8.

Fluoxetine potentiation of methylphenidate-induced neuropeptide expression in the striatum occurs selectively in direct pathway (striatonigral) neurons.

Van Waes V, Carr B, Beverley JA, Steiner H.

J Neurochem. 2012 Sep;122(5):1054-64. doi: 10.1111/j.1471-4159.2012.07852.x. Epub 2012 Jul 23.

9.

Juvenile administration of concomitant methylphenidate and fluoxetine alters behavioral reactivity to reward- and mood-related stimuli and disrupts ventral tegmental area gene expression in adulthood.

Warren BL, Iñiguez SD, Alcantara LF, Wright KN, Parise EM, Weakley SK, Bolaños-Guzmán CA.

J Neurosci. 2011 Jul 13;31(28):10347-58. doi: 10.1523/JNEUROSCI.1470-11.2011.

10.

National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.

Comer JS, Olfson M, Mojtabai R.

J Am Acad Child Adolesc Psychiatry. 2010 Oct;49(10):1001-10. doi: 10.1016/j.jaac.2010.07.007. Epub 2010 Sep 1.

11.

Selective serotonin reuptake inhibitor antidepressants potentiate methylphenidate (Ritalin)-induced gene regulation in the adolescent striatum.

Van Waes V, Beverley J, Marinelli M, Steiner H.

Eur J Neurosci. 2010 Aug;32(3):435-47. doi: 10.1111/j.1460-9568.2010.07294.x.

12.

The dopamine dilemma: using stimulants and antipsychotics concurrently.

Yanofski J.

Psychiatry (Edgmont). 2010 Jun;7(6):18-23.

13.

A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder.

Carlson GA, Dunn D, Kelsey D, Ruff D, Ball S, Ahrbecker L, Allen AJ.

Child Adolesc Psychiatry Ment Health. 2007 Sep 27;1(1):10.

Supplemental Content

Support Center